[Effects of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on expectoration, respiratory function, hepatic and cardiac function of subjects with chronic bronchopneumopathies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D004562:Electrocardiography; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D013147:Spirometry; D014050:Toluene / Q000627:therapeutic use*
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Effetti del N-cicloesil-N-metil-(2-amino-3,5-dibromobenzil)-ammonio cloruro sulla espettorazione, la funzione respiratoria, la funzionalità epatica e cardiaca di soggetti broncopneumopatici cronici.